Pre-medication regimen showed an infusion-related reaction rate of 22.5 percent with intravenous RYBREVANT ®, a three-fold reduction from 67.4 percent historically seen with standard IRR management ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. The incidence of infusion reactions was 47.7% (n = 31) with the combination ...

Please provide your email address to receive an email when new articles are posted on . FORT WORTH, Texas — Rheumatology nurses who serve patients in infusion centers can help prevent reactions by ...

Briumvi (ublituximab-xiiy) is a brand-name solution for intravenous infusion prescribed for certain forms of multiple sclerosis and clinically isolated syndrome in adults. As with other drugs, Briumvi ...

Darzalex (daratumumab) can cause a range of side effects from mild to severe, including infusion reactions, low blood cell counts, and respiratory infections. While most Darzalex side effects are mild ...

Monoclonal antibodies (elotuzumab and daratumumab) are the newest class of drugs that have proven to be efficacious antimyeloma agents. Although daratumumab, a CD38 monoclonal antibody, has ...

Sept. 15, 2005 — The U.S. Food and Drug Administration (FDA), ImClone Systems, Inc., and Bristol-Myers Squibb Co. have notified healthcare professionals via letter of recommendations for observation ...

As with any new cancer therapy, a learning curve exists in clinical practice to optimize drug administration. Although hematologists are comfortable with managing myelosuppression and GI toxicity, the ...

Maintenance doses of the biologic agent infliximab (Remicade) can be safely administered at a patient's home with a very low rate of adverse events (AEs) and serious AEs, according to research ...

Gazyva is a prescription injection medicine used for people with certain cancers, such as chronic lymphocytic leukemia (CLL) and certain types of follicular lymphoma. It is a type of medicine known as ...

Briumvi (ublituximab-xiiy) is a prescription drug used to treat certain types of multiple sclerosis (MS). Briumvi can cause side effects that range from mild to serious. Examples include upper ...